Hologenix, LLC Completes Science Advisory Board
NEW YORK, April 19, 2012 /PRNewswire/ — Hologenix, LLC, makers of Celliant, the leading innovative, responsive textile technology for apparel, body therapy, bedding and veterinary products, announces the completion of its Science Advisory Board and the establishment of their Research and Development Laboratory. The final two appointments to the Board are Dr.Lawrence A. Lavery (Diabetes and Wound Care) and Dr. Michael R. Hamblin (Photomedicine).
Currently a professor of surgery at University of Texas Southwestern Medical Center, Dr. Lavery is also the Vice Chair of Medical Affairs, Chronic Disease Specialists. He has served on the editorial board for Diabetes Care and has been published in more than 140 peer-reviewed publications. He is also the former chair of the American Diabetes Association Foot Care Council.
With over 30 years of experience, Dr. Hamblin is the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital and is an Associate Professor of Dermatology at Harvard Medical School. He is also a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. For the past seven years, Dr. Hamblin has chaired an annual conference at SPIE Photonics West entitled “Mechanisms for Low-Light Therapy.”
Dr. Lavery and Dr. Hamblin join Dr. Christopher Drake (Sleep Medicine) and Dr. Shimon Weiss(Nanotechnology). Dr. Michael Coyle, Chief Science Officer for Hologenix, LLC, chairs the Science Advisory Board and provides expertise in Human Performance.
“We’re thrilled to have such an impressive board of contributors,” says Seth Casden, CEO of Hologenix, LLC. “Each member offers a wealth of knowledge in their respective field and will greatly assist us in our mission to develop products that improve the quality of people’s lives.”
To coincide with its completion of the Science Advisory Board, Hologenix, LLC has established a Research and Development Laboratory, which has been approved to collect data for the purpose of generating original research for the peer-review process and publication. The Laboratory will work closely with the members of the Science Advisory Board, along with additional collaborators, to maximize its contributions.
Celliant® is a revolutionary, patented technology that harnesses and recycles the body’s natural energy through the medium of fibers. Celliant’s applied science utilizes a blend of minerals and proprietary ingredients that are embedded into the core of the fiber. Products containing this technology have been clinically proven to enhance tissue oxygen levels, improving athletic performance, sleep quality, health and wellness. Celliant technology is found in some of the world’s most recognized name brands. www.celliant.com
About Hologenix, LLC
Founded in 2003, Hologenix, LLC, maker of Celliant technology, is committed to creating and bringing to market products that enhance people’s lives through new materials. They strive to deliver the future of healthy innovation through a variety of consumer categories. The Company continues to explore new territories and is currently running FDA-focused, clinical trials to expand into the medical product arena.